Celldex Therapeutics Inc (CLDX.OQ)
- Adding an experimental Celldex Therapeutics Inc vaccine that enlists the immune system to fight cancer to standard therapy helped patients with the deadliest type of brain cancer live longer, according to data from a midstage trial presented on Sunday.
May 31 - Adding an experimental Celldex Therapeutics Inc vaccine that enlists the immune system to fight cancer to standard therapy helped patients with the deadliest type of brain cancer live longer, according to data from a midstage trial presented on Sunday.
|Takeda Pharmaceutical Co Ltd (4502.T)||¥6,301||--|
|Pfizer Inc. (PFE.N)||$36.15||+0.09|
|Merck & Co., Inc. (MRK.N)||$59.05||+0.09|
|Roche Holding Ltd. (ROG.VX)||CHF279.60||+0.50|
|Sanofi SA (SASY.PA)||€98.64||+0.67|
|GlaxoSmithKline plc (GSK.L)||1,400.00p||+4.00|
|Eli Lilly and Co (LLY.N)||$84.14||-0.37|
|Baxter International Inc (BAX.N)||$39.51||-0.57|
|Alexion Pharmaceuticals, Inc. (ALXN.OQ)||$195.73||-1.71|
|Dendreon Corporation (DNDNQ.PK)||--||--|
Earnings vs. Estimates
Analyst Research Reports
Provider : ValuEngine, Inc.
Trading Report for (CLDX). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : Thomson Reuters Stock Report
Provider : New Constructs, LLC
Celldex Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.